These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
940 related articles for article (PubMed ID: 7560608)
21. [Therapy of atrial fibrillation with class III anti-arrhythmia agents]. Follath F; Candinas R; Frielingsdorf J Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249 [TBL] [Abstract][Full Text] [Related]
22. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550 [TBL] [Abstract][Full Text] [Related]
23. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods. Naegeli B; Straumann E; Bertel O Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188 [TBL] [Abstract][Full Text] [Related]
25. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study]. Bellandi F; Dabizzi RP; Niccoli L; Cantini F; Palchetti R G Ital Cardiol; 1996 Apr; 26(4):379-90. PubMed ID: 8707022 [TBL] [Abstract][Full Text] [Related]
26. Is oral sotalol effective in converting atrial fibrillation to sinus rhythm? Ferreira E; Sunderji R; Gin K Pharmacotherapy; 1997; 17(6):1233-7. PubMed ID: 9399605 [TBL] [Abstract][Full Text] [Related]
27. Comparison of a standard versus accelerated dosing regimen for D,L-sotalol for the treatment of atrial and ventricular dysrhythmias. Kim RJ; Juriansz GJ; Jones DR; Gerling BR; Holzberger PT; Greenberg ML Pacing Clin Electrophysiol; 2006 Nov; 29(11):1219-25. PubMed ID: 17100674 [TBL] [Abstract][Full Text] [Related]
28. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746 [TBL] [Abstract][Full Text] [Related]
29. Comparison of QT dispersion during atrial fibrillation and sinus rhythm in the same patients, at normal and prolonged ventricular repolarization. Houltz B; Darpö B; Swedberg K; Blomström P; Crijns HJ; Jensen SM; Svernhage E; Edvardsson N Europace; 2000 Jan; 2(1):20-31. PubMed ID: 11225593 [TBL] [Abstract][Full Text] [Related]
30. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873 [TBL] [Abstract][Full Text] [Related]
31. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990 [TBL] [Abstract][Full Text] [Related]
32. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. Mason JW N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150 [TBL] [Abstract][Full Text] [Related]
33. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [TBL] [Abstract][Full Text] [Related]
34. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741 [TBL] [Abstract][Full Text] [Related]
35. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study]. Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070 [TBL] [Abstract][Full Text] [Related]
36. Aggravation of postcardioversion atrial dysfunction by sotalol. Pollak A; Falk RH J Am Coll Cardiol; 1995 Mar; 25(3):665-71. PubMed ID: 7860911 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillation. SOCESP Investigators. The Cardiology Society of São Paulo. de Paola AA; Veloso HH Am J Cardiol; 1999 Nov; 84(9):1033-7. PubMed ID: 10569659 [TBL] [Abstract][Full Text] [Related]
38. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Juul-Möller S; Edvardsson N; Rehnqvist-Ahlberg N Circulation; 1990 Dec; 82(6):1932-9. PubMed ID: 2242519 [TBL] [Abstract][Full Text] [Related]
39. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638 [TBL] [Abstract][Full Text] [Related]
40. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports. Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]